Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2003
07/22/2003US6596311 Multiparticulate drug, disintegrants, water insoluble and soluble inorganic excipients; nonbrittle; controlled, sus-tained or targeted release; gastric protection; taste masking
07/22/2003US6596310 Method of artificial insemination by timed release of sperm from capsules or solid beads
07/22/2003US6596309 Together with lipophilic silicone oil carriers in the form of a soft gelatin capsule
07/22/2003US6596308 Controlled release pharmaceutical composition
07/22/2003US6596307 Crystalline cefaclor with reduced water content
07/22/2003US6596306 Palm olein or soybean oil and surfactant system comprised of caprylocaproyl macrogolglycerides and polyoxyethylene 20 sorbitan monooleate; instantly emulsifies with gastrointes-tenal fluid; enhanced bioavailability and absorption
07/22/2003US6596305 Method of controlling the size of liposomes
07/22/2003US6596299 Delivering and retaining solution of sulfuric acid and sulphonated phenolics to teeth pockets; eliminates pain; reverses tissue damage
07/22/2003US6596298 Pullulan and antimicrobially effective amounts of thymol, methyl salicylate, eucalyptol and menthol
07/22/2003US6596297 Biodegradable microbicidal vaginal barrier device
07/22/2003US6596296 Three dimensional matrices for growing cells; controlled delivery of therapeutic agents
07/22/2003US6596295 Aqueous solution for treating degenerative or autoimmune diseases and/or as an immunomodulatory agent
07/22/2003US6596289 Knitted garment of cotton, nylon or polyester adapted for tight fitting; contains polyimine which partially decomposes from exposure to skin pH, moisture and/or heat releasing ascorbic acid, lipoic acid and/or isoflavones
07/22/2003US6596287 Products for topical applications comprising oil bodies
07/22/2003US6596286 Topical moisture regulating compositions
07/22/2003US6596284 Treating eczema with a combination of isotonic saline ocean® and nasal mast cell stabilizers
07/22/2003US6596278 Immunological response potentiation process
07/22/2003US6596262 Modulated release particles for aerosol delivery
07/22/2003US6596261 Maximizing drug delivery to lungs
07/22/2003US6596260 Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
07/22/2003US6596206 Generation of pharmaceutical agent particles using focused acoustic energy
07/22/2003US6595951 Closure system for an active agent delivert device
07/22/2003US6595678 Mixing apparatus
07/22/2003US6595209 Dry powder delivery system
07/22/2003CA2353693C Pharmaceutical composition containing citalopram
07/22/2003CA2269923C Pharmaceutical compositions containing plasma protein
07/22/2003CA2243274C Male contraceptive implant
07/22/2003CA2189328C Tocopherol compositions for delivery of biologically active agents
07/22/2003CA2117769C Liposome composition
07/22/2003CA2102185C Process for the preparation of nanoparticles
07/22/2003CA2041539C Periodontal barrier and method for aiding periodontal tissue regeneration
07/21/2003CA2416791A1 A receptor-ligand pairing for immune response
07/21/2003CA2368656A1 Receptor-ligand pairing for anti-inflammatory response
07/18/2003CA2368525A1 Composite pellets and method and apparatus for forming composite pellets
07/17/2003WO2003057862A2 Transdifferentiation of pancreatic acinar cells
07/17/2003WO2003057852A2 Purification and characterization of hla proteins
07/17/2003WO2003057745A1 Non-aqueous absorbent and use thereof
07/17/2003WO2003057359A2 Microparticles and methods for their production
07/17/2003WO2003057296A1 Apparatuses and methods for automatically assessing and monitoring a patient's responsiveness
07/17/2003WO2003057278A2 Drug delivery system for sustained delivery of glipizide
07/17/2003WO2003057264A1 Feminine care products for the delivery of therapeutic substances
07/17/2003WO2003057256A1 Hard capsules
07/17/2003WO2003057226A1 Use of phospholipids in peritoneal dialysis
07/17/2003WO2003057218A1 Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof
07/17/2003WO2003057208A1 Taxane based compositions and methods of use
07/17/2003WO2003057199A1 Adhesive and binding agent for dermal or transdermal treatment systems
07/17/2003WO2003057198A1 Pharmaceutical formulations with modified release
07/17/2003WO2003057197A1 Novel pharmaceutical dosage forms and method for producing same
07/17/2003WO2003057196A1 Drug mixture with enhanced dissolution rate
07/17/2003WO2003057195A1 Pravastatin pharmaceutical formulations and methods of their use
07/17/2003WO2003057194A1 Sterile filtered nanoparticule formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
07/17/2003WO2003057193A1 Monoterpene compositions and uses thereof
07/17/2003WO2003057192A1 Enhanced liposomal thioretinaco ozonide compositions and liposomal carrier
07/17/2003WO2003057191A1 Efficient liposomal encapsulation
07/17/2003WO2003057190A1 Efficient nucleic acid encapsulation into medium sized liposomes
07/17/2003WO2003057189A1 Efficient liposomal encapsulation under mild conditions
07/17/2003WO2003057188A1 Delivery of caffeine through an inhalation route
07/17/2003WO2003057187A1 Combinations of viscoelastics for use during surgery
07/17/2003WO2003057175A2 Amine functionalized superparamagnetic nanoparticles for the synthesis of bioconjugates and uses therefor
07/17/2003WO2003057170A2 Oral insulin therapy
07/17/2003WO2003057166A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
07/17/2003WO2003057164A2 Compounds for delivering substances into cells
07/17/2003WO2003057155A2 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor
07/17/2003WO2003057153A2 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
07/17/2003WO2003057151A2 A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
07/17/2003WO2003057150A2 A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
07/17/2003WO2003057141A2 Methods for improving the aesthetic appearance of skin
07/17/2003WO2003057136A2 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
07/17/2003WO2003057135A2 Aqueous compositions containing metronidazole
07/17/2003WO2003057133A2 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders
07/17/2003WO2003057128A2 Lipid particles and suspensions and uses thereof
07/17/2003WO2003056951A2 Antimicrobial body covering articles
07/17/2003WO2003056931A1 Chewing gum composition for eliminating nicotine
07/17/2003WO2003040398A3 Proteins stabilized with polysaccharide gums
07/17/2003WO2003039488A3 A method for treating inflammatory bowel disease
07/17/2003WO2003033097A3 Rotor-stator apparatus and process for the formation of particles
07/17/2003WO2003022252A3 Combinatorial type (several vehicles within a housing) controlled release drug delivery device
07/17/2003WO2003000184A3 Truncated apolipoprotein b-containing lipoprotein particles for delivery of components to tissues or cells
07/17/2003WO2002080881A3 Process for making protein delivery matrix and uses thereof
07/17/2003WO2002055693A3 Method for inhibiting the expression of a target gene
07/17/2003WO2002055020A3 Topical testosterone formulations and associated methods
07/17/2003WO2002032396A9 Lipid-protein-sugar particles for delivery of nucleic acids
07/17/2003WO2002030264A3 Microchip reservoir devices using wireless transmission of power and data
07/17/2003WO2002003973A3 Compositions comprising isosorbide dinitrate and methods for treatment of anal fissure
07/17/2003WO2002000171A3 Composition for delivery of hematopoietic growth factor
07/17/2003WO1999044581A3 Pharmaceutical composition of topiramate
07/17/2003US20030135202 Implantable osmotic pump
07/17/2003US20030135201 Microneedle with membrane
07/17/2003US20030135195 Mixture of colloidal aliphatic polyurethane, an aqueous dilution of PVP and specific dendrimers to enhance the physical integrity of the coating, to improve adhesion and to covalently bind an anticoagulant or antibiotic drug
07/17/2003US20030135160 Infusion device and driving mechanism for same
07/17/2003US20030135153 Drug implant injection device
07/17/2003US20030135113 Method of drug delivery to interstitial regions of the myocardium
07/17/2003US20030134908 Pharmaceutical compositions
07/17/2003US20030134906 Modified release pharmaceutical composition containing bupropion HCI as active substance
07/17/2003US20030134903 Substituted aminoalkanoate or substituted aminoalkyl alkanoate as a penetration enhancer a shear-thinning polysaccharide, a lipophilic compound, and an acidic buffer system.
07/17/2003US20030134892 Compositions for treatment of head and neck cancers, and methods of making and using the same
07/17/2003US20030134887 Orally administering celecoxib formulated in such a way as to provide a blood plasma concentration profile of celecoxib of 250 ng/ml in not later than 30 minutes
07/17/2003US20030134878 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
07/17/2003US20030134861 Transmucosal phosphodiesterase inhibitors for the treatment of erectile dysfunction
07/17/2003US20030134832 Synthetic steroids and particularly to oestrene derivatives. Specifically, the invention relates to stabilized compositions of tibolone (7 alpha , 17 alpha 17-hydroxy-7-methyl-19-nor-17-pregn 5(10)-en-20-yn-3-one and
1 ... 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 ... 2991